SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India informs about newspaper advertisement

03 Jul 2021 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, Abbott India has informed that it has enclosed the Public Notice, informing about the Seventy-seventh Annual General Meeting of the Company along with the details of the remote e-voting facility and e-voting at the Annual General Meeting, Book Closure dates and Dividend, published in the Business Standard (All Editions) and Loksatta on Saturday, July 3, 2021.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

25578.90 -218.25 (-0.85%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×